Financial Results for March 31, 2013 (Audited)
FDC Ltd has informed BSE about the Financial Results for the period ended March 31, 2013.24-05-2013
24-05-2013
Board to consider Dividend
FDC Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 24, 2013, inter alia, to consider and approve the Audited Financial Results of the Company for the year ended March 31, 2013.The Company has further informed that the board will also inter-alia consider the recommendation of dividend, if any, for the year ended March 31, 2013.26-04-2013
Disclosures under Reg.13(4) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Dr.Satish S Ugrankar has submitted the disclosures under Reg.13(4) of SEBI (Prohibition of Insider Trading) Regulations, 199208-04-2013
Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
FDC Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 199208-04-2013
Financial Results & Limited Review for Dec 31, 2012
FDC Ltd has informed BSE about the Financial Results & a copy of the Limited Review Report for the period ended December 31, 2012.02-02-2013
Clarifies on News Item
With reference to the news item appearing in a leading financial daily titled "Pharma Back on M&A; Street, FDC Owners in Talks to Exit", FDC Ltd has clarified to BSE that the above news is completely false and baseless.24-12-2012
Limited Review for Sep 30, 2012
FDC Ltd has submitted to BSE a Copy of the Limited Review Report for the period ended September 30, 2012.05-11-2012
Financial Results for Sep 30, 2012
FDC Ltd has informed BSE about the Financial Results for the period ended September 30, 2012.05-11-2012
Updates on Buy back Offer
FDC Ltd has submitted to BSE a Copy of Announcement regarding buy back of equity shares of FDC Ltd ("Target Company") (For more details kindly refer Corporate Announcements on www.bseindia.com).31-08-2012